Chemical Research Report Xylo-oligosaccharides Market | Page 2

Popularity and increasing consumption of prebiotics is projected to boost demand for
xylo-oligosaccharide in the forecast period. According to U.S. Department of Health &
Human Services, the consumption of prebiotics and probiotics by adults in the U.S. has
increased by four times during 2012 – 2007.
However, production of xylo-oligosaccharides requires large amount of investment and
costly & specialized equipment. Moreover, production of xylo-oligosaccharides generates
unwanted products such as furfural and hydroxymethyl furfural in the mixture of XOS
which can cause skin allergy, such disadvantages may restraint growth of the xylo-
oligosaccharides market.
Market Outlook
Among applications, neutraceuticals & pharmaceuticals segment accounted for the
highest market share in the global xylo-oligosaccharides market in 2017. This is due to
various advantages of XOS such as water binding capacity, sweetening ability, and fat
replacement value. Moreover, xylo-oligosaccharides have a host of health benefits such
as it act as an anti-allergic, antioxidant, and anti-inflammatory. Such advantages will
attract more pharmaceuticals & neutraceuticals companies to adopt xylo-
oligosaccharides as a non-digestible sugar in their products.
North America held the highest market share in the global xylo-oligosaccharides market
in 2017 and is projected to remain the dominant region during the forecast period. This is
due to rising health awareness among consumers. According to U.S. Department of
Health & Human Services, 3.9 million adult population consumed prebiotic or probiotic
products in 2016.
Asia Pacific is projected to be the fastest growing region in the market over the forecast
period, owing to increasing number of pharmaceutical industries and rising incidence of
diabetes in the region. For instance, according to Indian Brand Equity Foundation (IBEF),
pharmaceutical industry is the third-largest industry in India in terms of volume and
accounted for around 20% of the global pharmaceutical industries in 2017. Asia is home
to most diabetic patients in the world. In 2017, according to International Diabetes
Federation, diabetic population of India and China accounted for 8.8% and 10.9% of the
total adult’s diabetic population of the respective countries.
Key Players in Global Xylo-oligosaccharides market
Key players operating in the global xylo-oligosaccharides market include Fengyuan
Zhongke, Hebi Taixin, Hengfeng Sugar, Huaian Baimai Keyu, Kanwei Biologic, Longlive,
Suntory,Suzhou Xiankuo, and Yatai.